A New England Enrollment Center for PMI Cohort Program
新英格兰 PMI 队列计划招生中心
基本信息
- 批准号:9355397
- 负责人:
- 金额:$ 121.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-27 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdultAmbulatory CareAreaBostonCaringCatchment AreaCensusesClinical DataCollaborationsCollectionComplementConsentDataData ReportingElectronicsEnrollmentEvaluationFutureGeographyGoalsHealth PersonnelHealth StatusHealth systemHealthcare SystemsInformation TechnologyLifeMedical centerMinorityNamesNetwork-basedNew EnglandPMI cohortParticipantPatient RecruitmentsPatientsPerformancePersonsPhilosophyPhysiciansPoliciesPopulationPrecision Medicine InitiativeProceduresProcessProtocols documentationRecontactsRecording of previous eventsRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch SupportSamplingServicesShippingShipsStructureSurveysTarget PopulationsTeaching HospitalsTechnologyTestingUniversitiesbasebiobankclinical infrastructurecohortdemographicsinnovationmedical schoolsmeetingsprogramssample collectiontransmission processvolunteer
项目摘要
We propose the creation of “Precision Medicine Initiative New England” (PMI-NE), an enrollment center that
encompasses two leading health care provider (HPO) organizations: Partners HealthCare System (PHS) and
Boston Medical Center (BMC), the primary teaching hospital of Boston University School of Medicine (BU). We
will provide essential geographic diversity in the Northeast Census Region of the US by complementing the
Middle Atlantic Division (NJ, NY, and PA; covered in the Columbia and Pittsburgh PMC HPOs) with the New
England Division (CT, ME, MA, NH, RI, and VT). Together, PHS and BMC serve a catchment area of 14.4
million people including a large and diverse proportion of the 4.4 million living in the greater Boston area, large
portions of the New England population, and a worldwide referral base. Over a five-year period, PHS and BMC
delivered outpatient care to 2,253,618 patients with 863,429 (38%) meeting our recruitment target
population criteria. Our organizations have a long history of collaboratively producing and using common,
open-standards information technology (IT) that leverages the health care system for discovery and has been
adopted nationally and internationally. PHS has already implemented brisk recruitment of patients (more than
46,000 to date, 2,200 consented per month) into the PHS Biobank with many key components of PMI including
broad consent, linkage to EMR, electronic surveys, and recontact. In large cutting-edge projects, we have
successfully engaged participants as partners in research and sustained longitudinal engagement using
traditional as well as innovative IT approaches. As such, we have already developed and tested the IT and
clinical infrastructures that will be central to achieving PMI milestones and can rapidly adopt procedures
developed by the PMI Consortium. We have an extensive, successful track record of collaboration and
contributions to large-scale national networks, including the PCORNet Clinical Data Research Network based
at Harvard (named “SCiLHS”) in which PHS and BMC-BU collaborate, eMERGE, and many others (see Past
Performance). Our team, comprising diverse stakeholders (physicians, researchers, IT leaders, participants)
will cohere to enroll 10,000 patients (46% minority) in service of the PMI Cohort Program (PMI-CP). In the
sections that follow, we describe our approach to establishing our PMI-NE HPO and our contributions to the
PMI Consortium. We describe well-defined milestones and metrics over the 12-month period of performance.
我们建议创建“ Precision Medicine Initiative New England”(PMI-NE),这是一个入学中心
包括两个领先的医疗保健提供者(HPO)组织:合作伙伴医疗保健系统(PHS)和
波士顿医学中心(BMC),波士顿大学医学院(BU)的初级教学医院。我们
通过完成
中大西洋师(新泽西州,纽约和PA;哥伦比亚和匹兹堡PMC HPO覆盖)
英格兰分区(CT,ME,MA,NH,RI和VT)。 PHS和BMC一起提供14.4的集水区域
数百万人包括居住在大波士顿地区的440万人中的很大一部分
新英格兰人口的一部分和全球推荐基础。在五年内,PHS和BMC
向2,253,618例患者提供门诊护理,其中863,429(38%)达到我们的招聘目标
人口标准。我们的组织在共同生产和使用常见的历史上有很长的历史
利用医疗保健系统进行发现的开放标准信息技术(IT)
在国内和国际上采用。 PHS已经实施了对患者的轻快招募(超过
迄今为止的46,000,每月2,200份同意
广泛的同意,与EMR的联系,电子调查和重新连接。在大型尖端项目中,我们有
成功地参与参与者,作为研究的合作伙伴,并持续纵向参与
传统和创新的IT接近。因此,我们已经开发并测试了IT和
对于实现PMI里程碑至关重要的临床基础设施,可以快速采用程序
由PMI财团开发。我们拥有合作的广泛,成功的记录和
对大型国家网络的贡献,包括基于PCORNET临床数据研究网络
在哈佛大学(命名为“ Scilhs”),其中PHS和BMC-BU合作,Emerge和许多其他人(请参阅过去
表现)。我们的团队完成了潜水员利益相关者(医师,研究人员,IT领导者,参与者)
将在PMI队列计划(PMI-CP)服务中招募10,000名患者(46%的少数民族)。在
随后的部分,我们描述了建立PMI-NE HPO的方法以及我们对
PMI财团。我们在12个月的性能中描述了定义明确的里程碑和指标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH W KARLSON其他文献
ELIZABETH W KARLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH W KARLSON', 18)}}的其他基金
eMERGE Phase IV Clinical Center at Partners HealthCare
Partners HealthCare 的 eMERGE IV 期临床中心
- 批准号:
10230561 - 财政年份:2020
- 资助金额:
$ 121.12万 - 项目类别:
A New England Enrollment Center for PMI Cohort Program
新英格兰 PMI 队列计划招生中心
- 批准号:
9453746 - 财政年份:2016
- 资助金额:
$ 121.12万 - 项目类别:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
PARTNERS HEALTHCARE 新兴三期临床中心
- 批准号:
9493516 - 财政年份:2015
- 资助金额:
$ 121.12万 - 项目类别:
eMERGE Phase IV Clinical Center at Mass General Brigham
麻省总医院布里格姆分校 eMERGE IV 期临床中心
- 批准号:
10625354 - 财政年份:2015
- 资助金额:
$ 121.12万 - 项目类别:
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
PARTNERS HEALTHCARE 新兴三期临床中心
- 批准号:
8968123 - 财政年份:2015
- 资助金额:
$ 121.12万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Stroke Trials Network-Regional Coordinating Center University of Pittsburgh (STN-UP)
中风试验网络-匹兹堡大学区域协调中心 (STN-UP)
- 批准号:
10847050 - 财政年份:2023
- 资助金额:
$ 121.12万 - 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
- 批准号:
10707047 - 财政年份:2022
- 资助金额:
$ 121.12万 - 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
- 批准号:
10436056 - 财政年份:2022
- 资助金额:
$ 121.12万 - 项目类别:
Implementation of emergency department screening to impact rising syphilis rates in vulnerable populations
实施急诊科筛查以影响弱势群体不断上升的梅毒发病率
- 批准号:
10670922 - 财政年份:2022
- 资助金额:
$ 121.12万 - 项目类别: